Aylward E H, Li Q, Honeycutt N A, Warren A C, Pulsifer M B, Barta P E, Chan M D, Smith P D, Jerram M, Pearlson G D
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Md., USA.
Am J Psychiatry. 1999 Apr;156(4):564-8. doi: 10.1176/ajp.156.4.564.
This study sought to determine whether volumes of the hippocampus and amygdala are disproportionately smaller in subjects with Down's syndrome than in normal comparison subjects and whether volume reduction is greater in Down's syndrome subjects with dementia.
The subjects were 25 adults with Down's syndrome (eight with dementia) and 25 cognitively normal adults who were individually matched on age, sex, and race. Magnetic resonance imaging measures included volumes of the hippocampus, amygdala, and total brain. Nineteen of the Down's syndrome subjects had follow-up scans (interscan interval = 9-41 months).
Nondemented Down's syndrome subjects had significantly smaller volumes of the hippocampus, but not the amygdala, than their comparison subjects, even when total brain volume was controlled for. Volumes of both the hippocampus and the amygdala were smaller in the demented Down's syndrome subjects than in their comparison subjects, even when total brain volume was controlled for. Age was not correlated with volume of the hippocampus or amygdala among the nondemented Down's syndrome subjects and the comparison subjects; age was correlated with volume of the amygdala, but not the hippocampus, among the Down's syndrome subjects with dementia. Changes in volume over time were not statistically significant for either the demented or the nondemented subjects.
Hippocampal volume, while disproportionately small for brain size in individuals with Down's syndrome, remains fairly constant through the fifth decade of life in those without dementia. All subjects over age 50 who had Down's syndrome demonstrated volume reduction in the hippocampus as well as clinical signs of dementia. Dementia was also associated with volume reductions in the amygdala that exceeded reductions in total brain volume.
本研究旨在确定唐氏综合征患者海马体和杏仁核的体积是否比正常对照受试者明显更小,以及患有痴呆症的唐氏综合征患者的体积缩小是否更明显。
研究对象为25名成年唐氏综合征患者(8名患有痴呆症)和25名认知正常的成年人,他们在年龄、性别和种族方面进行了个体匹配。磁共振成像测量包括海马体、杏仁核和全脑的体积。19名唐氏综合征患者进行了随访扫描(两次扫描间隔时间为9 - 41个月)。
即使在控制全脑体积的情况下,非痴呆的唐氏综合征患者的海马体体积仍显著小于其对照受试者,但杏仁核体积无显著差异。即使在控制全脑体积的情况下,患有痴呆症的唐氏综合征患者的海马体和杏仁核体积均小于其对照受试者。在非痴呆的唐氏综合征患者和对照受试者中,年龄与海马体或杏仁核的体积无关;在患有痴呆症的唐氏综合征患者中,年龄与杏仁核体积相关,但与海马体体积无关。对于痴呆患者和非痴呆患者,体积随时间的变化均无统计学意义。
唐氏综合征患者的海马体体积相对于脑容量而言不成比例地小,但在50岁之前没有痴呆症的患者中,海马体体积保持相当稳定。所有50岁以上的唐氏综合征患者均表现出海马体体积缩小以及痴呆的临床症状。痴呆症还与杏仁核体积缩小有关,且杏仁核体积缩小超过了全脑体积的缩小。